These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23415374)

  • 61. Epigenetic silencing of checkpoint with fork-head associated and ring finger gene expression in esophageal cancer.
    Suzuki Y; Miyagi Y; Yukawa N; Rino Y; Masuda M
    Oncol Lett; 2014 Jan; 7(1):69-73. PubMed ID: 24348823
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Solitary pulmonary metastasis from lung cancer harboring EML4-ALK after a 15-year disease-free interval.
    Tomizawa K; Ito S; Suda K; Fukui T; Usami N; Hatooka S; Kuwano H; Yatabe Y; Mitsudomi T
    Lung Cancer; 2013 Apr; 80(1):99-101. PubMed ID: 23279872
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) rearrangement in congenital pulmonary airway malformation.
    Tetsumoto S; Kijima T; Morii E; Goya S; Minami T; Hirata H; Takahashi R; Kohmo S; Inoue K; Nagatomo I; Takeda Y; Kida H; Tachibana I; Kumanogoh A
    Clin Lung Cancer; 2013 Jul; 14(4):457-60. PubMed ID: 23357247
    [No Abstract]   [Full Text] [Related]  

  • 64. The diagnostic and prognostic value of
    Sun Z; Liu J; Jing H; Dong SX; Wu J
    Oncotarget; 2017 Oct; 8(51):89142-89148. PubMed ID: 29179506
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CHFR: a key checkpoint component implicated in a wide range of cancers.
    Sanbhnani S; Yeong FM
    Cell Mol Life Sci; 2012 May; 69(10):1669-87. PubMed ID: 22159584
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.
    Fukuda T; Kondo Y; Nakagama H
    PLoS One; 2008 Mar; 3(3):e1776. PubMed ID: 18335050
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer.
    Hagiwara T; Sugimoto K; Momose H; Irie T; Honjo K; Okazawa YU; Kawai M; Kawano S; Munakata S; Takahashi M; Kojima Y; Serizawa N; Nagahara A; Hoffman RM; Brock MV; Sakamoto K
    Anticancer Res; 2022 Feb; 42(2):697-707. PubMed ID: 35093868
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methylation of gene CHFR promoter in acute leukemia cells.
    Gong H; Liu W; Zhou J; Xu H
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):240-2. PubMed ID: 16201259
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Aberrant expression of CHFR in malignant peripheral nerve sheath tumors.
    Kobayashi C; Oda Y; Takahira T; Izumi T; Kawaguchi K; Yamamoto H; Tamiya S; Yamada T; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2006 Apr; 19(4):524-32. PubMed ID: 16554732
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.
    Privette LM; González ME; Ding L; Kleer CG; Petty EM
    Cancer Res; 2007 Jul; 67(13):6064-74. PubMed ID: 17596595
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hypermethylation of the Dal-1 gene in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
    Tsujiuchi T; Masaoka T; Sugata E; Onishi M; Fujii H; Shimizu K; Honoki K
    Mol Carcinog; 2007 Oct; 46(10):819-23. PubMed ID: 17415786
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of a genetic variant of CYP19A1 with multicentric development of lung adenocarcinomas.
    Ikeda K; Shiraishi K; Eguchi A; Osumi H; Matsuishi K; Matsubara E; Fujino K; Shibata H; Yoshimoto K; Mori T; Omori H; Suzuki M
    Ann Surg Oncol; 2014 Mar; 21(3):939-45. PubMed ID: 24242679
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    Sakanoue I; Hamakawa H; Fujimoto D; Imai Y; Minami K; Tomii K; Takahashi Y
    J Thorac Dis; 2017 Aug; 9(8):E694-E697. PubMed ID: 28932588
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Biomarker-based treatment selection in early-stage rectal cancer to promote organ preservation.
    Leong KJ; Beggs A; James J; Morton DG; Matthews GM; Bach SP
    Br J Surg; 2014 Sep; 101(10):1299-309. PubMed ID: 25052224
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma.
    Ikeda K; Shiraishi K; Koga T; Motooka Y; Fujino K; Shibata H; Mori T; Suzuki M
    Ann Thorac Surg; 2015 May; 99(5):1755-9. PubMed ID: 25827678
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nonsense and missense mutation of mitochondrial ND6 gene promotes cell migration and invasion in human lung adenocarcinoma.
    Yuan Y; Wang W; Li H; Yu Y; Tao J; Huang S; Zeng Z
    BMC Cancer; 2015 May; 15():346. PubMed ID: 25934296
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinicopathological significance of
    Wang C; Ma W; Wei R; Zhang X; Shen N; Shang L; E L; Wang Y; Gao L; Li X; Wang B; Zhang Y; Du A
    Oncotarget; 2017 Dec; 8(65):109732-109739. PubMed ID: 29312643
    [TBL] [Abstract][Full Text] [Related]  

  • 78. About molecular profile of lung cancer in Tunisian patients.
    Mezni F; Mlika M; Boussen H; Ghedira H; Fenniche S; Faten T; Loriot MA
    J Immunoassay Immunochem; 2018; 39(1):99-107. PubMed ID: 29308976
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Analysis of the methylation of CpG islands in the
    Maekawa H; Ito T; Orita H; Kushida T; Sakurada M; Sato K; Hulbert A; Brock MV
    Oncol Lett; 2020 Mar; 19(3):2197-2204. PubMed ID: 32194717
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).
    Muraki Y; Banno K; Yanokura M; Kobayashi Y; Kawaguchi M; Nomura H; Hirasawa A; Susumu N; Aoki D
    Oncol Rep; 2009 Nov; 22(5):967-72. PubMed ID: 19787208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.